NeurologyLive® Friday 5 — September 15, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Remote Intervention for Assessing Cognitive Dysfunction in Patients With Long COVID: Leigh Charvet, PhD

The professor of neurology at the NYU Grossman School of Medicine discussed the RECOVER-NEURO trial that is focused on improving cognitive dysfunction in patients with long COVID symptoms. [WATCH TIME: 5 minutes]

2: Tracking Major Milestones of Rare Neuroimmune Disorders

A group of panelists discussed the history of the Siegel Rare Neuroimmune Association, and the progress made on rare neuroimmune disorders in the nearly 30 years since its existence. [WATCH TIME: 6 minutes]

3: NeuroVoices: Joseph Sullivan, MD, on Exploring Antisense Oligonucleotides for Dravet Syndrome, Rare Epilepsies

In this recent Q&A, the director of the Pediatric Epilepsy Center at UCSF provided perspective on STK-001, a promising antisense oligonucleotide in development, and the shift in how Dravet syndrome is discussed and managed.

4: Collaborative Efforts for Health Equity in Alzheimer Disease Genetic Research: Adam Naj, PhD

The genetic epidemiologist at the University of Pennsylvania discussed a recent study that highlighted the importance of diverse samples in genetic research for Alzheimer disease in helping to uncover hidden genetic risk factors. [WATCH TIME: 2 minutes]

5: Investigating Regional and Ethnic Variations in Alzheimer Disease and Cognitive Health: Kumar B. Rajan, PhD

The professor in the department of internal medicine at RUSH Medical College discussed a study aimed to provide insights to help tailor cognitive decline prevention programs and raise awareness about health disparities in minority populations. [WATCH TIME: 5 minutes]